Darzalex (daratumumab) Receives Positive Opinion from European CHMP for High-Risk Smoldering Multiple Myeloma Patients (https://www.myeloma.org/news-events/multiple-myeloma-news/chmp-positive-opinion-darzalex-daratumumab-hrsmm)